THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.0% of their position (30K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 2 sales
Filed: 6/3/2022ACC: 0001493152-22-015845
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-30K
Net shares
Net seller
$0.00
Total acquired
2
Open market trades
0B · 2S
2
Total transactions
30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−20K
Price / share
—
Trade value
—
% of position
0.0%
6/1/2022
202.73M→202.71M
Common Stock
Direct
Shares
−10K
Price / share
—
Trade value
—
% of position
0.0%
6/2/2022
202.71M→202.70M
Total
Net shares
−30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2022 | S · Sale | −20K | — | — | 0.0% | 202.73M | 202.71M |
| Common Stock Direct | 6/2/2022 | S · Sale | −10K | — | — | 0.0% | 202.71M | 202.70M |
| Total | −30K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported